A Multi-organ, Feto-maternal Interface Organ-on-chip, Models Pregnancy Pathology and is a Useful Preclinical Extracellular Vesicle Drug Trial Platform

Overview

Journal Extracell Vesicle

Date 2024 Jun 14

PMID 38872854

Authors

Melody Safarzadeh

Lauren S Richardson

Ananth Kumar Kammala

Angela Mosebarger

Mohamed Bettayeb

Sungjin Kim

Po Yi Lam

Enkhtuya Radnaa

Arum Han

Ramkumar Menon

Affiliations

Soon will be listed here.

Abstract

Pregnant women and their fetuses are often excluded from clinical trials due to missing drug-related pre-clinical trial information at the human feto-maternal interface (FMi). The two interfaces-placenta/decidua and fetal membranes/decidua are gatekeepers of drug transport; however, testing their functions is impractical during pregnancy. Limitations of current / models have hampered drug development and testing during pregnancy. Hence, major complications like preterm births and maternal and neonatal mortalities remain high. Advancements in organ-on-chip (OOC) platforms to test drug kinetics and efficacy and novel extracellular vesicle-based fetal drug delivery are expected to accelerate preclinical trials related to pregnancy complications. Here we report the development and testing of a humanized multi-organ fetal membrane/placenta (fetal)-decidua (maternal) interface OOC (FMi-PLA-OOC) that contains seven cell types interconnected through microchannels to maintain intercellular interactions as seen . Cytotoxicity, propagation, mechanism of action, and efficacy of engineered extracellular vesicles containing anti-inflammatory interleukin (IL)-10 (eIL-10) were evaluated to reduce FMi inflammation associated with preterm birth. A healthy and disease model (lipopolysaccharide-infectious inflammation) of the FMi-PLA-OOC was created and co-treated with eIL-10. eIL-10 propagated from the maternal to fetal side within 72-hours, localized in all cell types, showed no cytotoxicity, activated IL-10 signaling pathways, and reduced lipopolysaccharide-induced inflammation (minimized NF-kB activation and proinflammatory cytokine production). These data recapitulated eIL-10s' ability to reduce inflammation and delay infection-associated preterm birth in mouse models, suggesting FMi-PLA-OOC as an alternative approach to using animal models. Additionally, we report the utility of eIL-10 that can traverse through FMis to reduce inflammation-associated pregnancy complications.

Citing Articles

Extracellular RNA communication: A decade of NIH common fund support illuminates exRNA biology.

Amolegbe S, Johnston N, Ambrosi A, Ganguly A, Howcroft T, Kuo L J Extracell Vesicles. 2025; 14(1):e70016.

PMID: 39815775 PMC: 11735951. DOI: 10.1002/jev2.70016.

Group B streptococcal infections in pregnancy and early life.

Manuel G, Twentyman J, Noble K, Eastman A, Aronoff D, Seepersaud R Clin Microbiol Rev. 2024; 38(1):e0015422.

PMID: 39584819 PMC: 11905376. DOI: 10.1128/cmr.00154-22.

Lead exposure at the feto-maternal interface: a cause for concern for fetal membrane trophoblasts.

Flores-Espinosa P, Menon R, Kammala A, Ananth K, Richardson L, Richardson L Toxicol Sci. 2024; 203(2):195-205.

PMID: 39579145 PMC: 11775422. DOI: 10.1093/toxsci/kfae149.

References

Morales I, Boghdady C, Campbell B, Moraes C . Integrating mechanical sensor readouts into organ-on-a-chip platforms. Front Bioeng Biotechnol. 2023; 10:1060895. PMC: 9800895. DOI: 10.3389/fbioe.2022.1060895. View

Jagadeesan S, Workman M, Herland A, Svendsen C, Vatine G . Generation of a Human iPSC-Based Blood-Brain Barrier Chip. J Vis Exp. 2020; (157). DOI: 10.3791/60925. View

Wang J, Khodabukus A, Rao L, Vandusen K, Abutaleb N, Bursac N . Engineered skeletal muscles for disease modeling and drug discovery. Biomaterials. 2019; 221:119416. PMC: 7041662. DOI: 10.1016/j.biomaterials.2019.119416. View

An F, Qu Y, Liu X, Zhong R, Luo Y . Organ-on-a-Chip: New Platform for Biological Analysis. Anal Chem Insights. 2015; 10:39-45. PMC: 4664205. DOI: 10.4137/ACI.S28905. View

Kimura H, Sakai Y, Fujii T . Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab Pharmacokinet. 2017; 33(1):43-48. DOI: 10.1016/j.dmpk.2017.11.003. View

Richardson L, Radnaa E, Lintao R, Urrabaz-Garza R, Maredia R, Han A . A Microphysiological Device to Model the Choriodecidual Interface Immune Status during Pregnancy. J Immunol. 2023; 210(9):1437-1446. PMC: 10121841. DOI: 10.4049/jimmunol.2200821. View

Gnecco J, Anders A, Cliffel D, Pensabene V, Rogers L, Osteen K . Instrumenting a Fetal Membrane on a Chip as Emerging Technology for Preterm Birth Research. Curr Pharm Des. 2017; 23(40):6115-6124. DOI: 10.2174/1381612823666170825142649. View

Dodson K, Echevarria F, Li D, Sappington R, Edd J . Retina-on-a-chip: a microfluidic platform for point access signaling studies. Biomed Microdevices. 2015; 17(6):114. PMC: 4707151. DOI: 10.1007/s10544-015-0019-x. View

Richardson L, Gnecco J, Ding T, Osteen K, Rogers L, Aronoff D . Fetal Membrane Organ-On-Chip: An Innovative Approach to Study Cellular Interactions. Reprod Sci. 2019; :1933719119828084. DOI: 10.1177/1933719119828084. View

10.

Nagashima J, El Assal R, Songsasen N, Demirci U . Evaluation of an ovary-on-a-chip in large mammalian models: Species specificity and influence of follicle isolation status. J Tissue Eng Regen Med. 2017; 12(4):e1926-e1935. PMC: 5906142. DOI: 10.1002/term.2623. View

11.

Hao S, Ha L, Cheng G, Wan Y, Xia Y, Sosnoski D . A Spontaneous 3D Bone-On-a-Chip for Bone Metastasis Study of Breast Cancer Cells. Small. 2018; 14(12):e1702787. DOI: 10.1002/smll.201702787. View

12.

Yin F, Zhu Y, Zhang M, Yu H, Chen W, Qin J . A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. Toxicol In Vitro. 2018; 54:105-113. DOI: 10.1016/j.tiv.2018.08.014. View

13.

Mittal R, Woo F, Castro C, Cohen M, Karanxha J, Mittal J . Organ-on-chip models: Implications in drug discovery and clinical applications. J Cell Physiol. 2018; 234(6):8352-8380. DOI: 10.1002/jcp.27729. View

14.

Haderspeck J, Chuchuy J, Kustermann S, Liebau S, Loskill P . Organ-on-a-chip technologies that can transform ophthalmic drug discovery and disease modeling. Expert Opin Drug Discov. 2018; 14(1):47-57. DOI: 10.1080/17460441.2019.1551873. View

15.

Crampton S, Davis J, Hughes C . Isolation of human umbilical vein endothelial cells (HUVEC). J Vis Exp. 2008; (3):183. PMC: 2576276. DOI: 10.3791/183. View

16.

Romero R, Dey S, Fisher S . Preterm labor: one syndrome, many causes. Science. 2014; 345(6198):760-5. PMC: 4191866. DOI: 10.1126/science.1251816. View

17.

Richardson L, Kim S, Menon R, Han A . Organ-On-Chip Technology: The Future of Feto-Maternal Interface Research?. Front Physiol. 2020; 11:715. PMC: 7338764. DOI: 10.3389/fphys.2020.00715. View

18.

Franca C, Tahayeri A, Sousa Rodrigues N, Ferdosian S, Rontani R, Sereda G . The tooth on-a-chip: a microphysiologic model system mimicking the biologic interface of the tooth with biomaterials. Lab Chip. 2019; 20(2):405-413. PMC: 7395925. DOI: 10.1039/c9lc00915a. View

19.

Maschmeyer I, Lorenz A, Schimek K, Hasenberg T, Ramme A, Hubner J . A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip. 2015; 15(12):2688-99. DOI: 10.1039/c5lc00392j. View

20.

Dixon C, Richardson L, Sheller-Miller S, Saade G, Menon R . A distinct mechanism of senescence activation in amnion epithelial cells by infection, inflammation, and oxidative stress. Am J Reprod Immunol. 2017; 79(3). PMC: 5815890. DOI: 10.1111/aji.12790. View